MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

BACKGROUND: The CD133 antigen is a marker of radio- and chemo-resistant stem cell populations in glioblastoma (GBM). The O(6)-methylguanine DNA methyltransferase (MGMT) enzyme is related with temozolomide (TMZ) resistance. Our propose is to analyze the prognostic significance of the CD133 antigen an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Melguizo, Consolación, Prados, Jose, González, Beatriz, Ortiz, Raul, Concha, Angel, Alvarez, Pablo Juan, Madeddu, Roberto, Perazzoli, Gloria, Oliver, Jaime Antonio, López, Rodrigo, Rodríguez-Serrano, Fernando, Aránega, Antonia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551841/
https://ncbi.nlm.nih.gov/pubmed/23245659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-250
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados